Skip to main content

Did's recent press release about Gradient violate Rule 10b-5?

On Tuesday, February 12, 2008 (NASDAQ: OSTK) issued a press release entitled, "Overstock Applauds Trial Court's Ruling in Gradient Case; Gradient Defendant Loses Dash for Exit as Court Sets September 9 Trial Date," hyping its litigation prospects in its ongoing lawsuit against Gradient Analytics, an independent research firm and Copper River Partners (formerly Rocker Partners), a short seller. However, failed to disclose in its press release the fact that Gradient Analytics recently filed a Motion for Leave to File a Cross-complaint against, Patrick Byrne, and others.

On Wednesday, the day after's press release, above, the company's stock rose to $11.58 per share from the previous closing price of $11.07 per share or a 4.6% increase (before the issuance of the press release).

Did violate Securities and Exchange Commission Rule 10b-5?

Let's review Securities and Exchange Commission Rule 10b-5:

It shall be unlawful for any person, directly or indirectly, by the use of any means or instrumentality of interstate commerce, or of the mails or of any facility of any national securities exchange,

a. To employ any device, scheme, or artifice to defraud,

b. To make any untrue statement of a material fact or to omit to state a material fact necessary in order to make the statements made, in the light of the circumstances under which they were made, not misleading, or

c. To engage in any act, practice, or course of business which operates or would operate as a fraud or deceit upon any person,

in connection with the purchase or sale of any security.

Note: Bold print and italics added by me.

As any securities attorney will tell you, Rule 10b-5 is the bedrock upon which federal securities law is built. Whether a public company violates GAAP, Regulation G governing non-GAAP financial disclosures, or generally any federal securities law, it is the presentation of untrue information or the omission of any material information that gives rise to fraud (as opposed to a technical violation, without consequence to the public) under the federal securities law.

If a public company issues any statement to the public, whether in a press release or an SEC filing, Rule 10b-5 mandates (DEMANDS) that the company include all material information in connection with the subject matter of the document.

According to the Securities and Exchange Commission:

Section 10(b) of the Exchange Act and Rule 10b-5 proscribe, among other things, misstatements of material fact made in connection with the purchase or sale of securities. Information is material if there is a substantial likelihood that its disclosure would be viewed by a reasonable investor as having significantly altered the total mix of information available.

Note: Bold print and italics added by me.

Information is material under the Rule:

(1) If it is more likely than not that such information if known to the reader would have been included his/her decision in connection with trading the securities of the company, or

(2) The information would alter the "mix of information" before the reader; therefore, if known would cause the reader to come to a different conclusion.'s press release cherry-picks one element of its litigation with the Gradient litigation, by pointing out that:

California Marin Superior Court Judge Lynn O'Malley Taylor ruled against Gradient Defendant Matthew Kliber's bid to exit the case. In addition, Judge O'Malley has set the case for trial on September 9, 2008.

In the press release, Jonathan E. Johnson III,'s Senior Vice President of Legal went on to hype the company's litigation prospects:

Once again, defendants' efforts to derail this case fall flat. In every instance the trial and appellate courts have ruled that Overstock has a 'reasonable probability' of prevailing on every claim, just as the California Supreme Court declined Defendants' Petition for Review of those decisions. They are out of running room -- and we now have a trial date set. It's time to bring their conduct into the light of day."

And Patrick Byrne continued his non-stop hyping of the company's litigation prospects:

These broad-tossers have given us a two-and-a half year cook's tour of the California appellate process. They engage in such legal posturing because they know this case will expose a widespread, illegal Wall Street practice that harms American companies and makes money at the expense of American investors. I look forward to the day when the scofflaws are no longer in a backroom seeing their orthodoxies supped by biddable regulators and tractable New York financial journalists, but are instead sitting in a California courtroom trying to rationalize their schemes to twelve citizens."

However,'s February 12 press release deliberately omits another new key element in its litigation: the fact that Gradient recently filed a motion for leave to file a cross-complaint. Gradient's cross-complaint, like Copper River's earlier cross-complaint covered in this blog, makes serious detailed allegations of willful misconduct and violations of law by, Patrick Byrne, and others. In addition, consistent with's pattern of failing to disclose material information to the public (like Byrne’s failure to disclose his personal subpoena), the company's website page covering the litigation fails to present a link to defendants’ cross complaints/countersuits, and omits any mention of, or even reference to, the existence of these material filings.

According to the "Proof of Service," and other Cross-Defendants (from the Copper River countersuit) were served on January 30, 2008 with the following documents:

1. Defendant Gradient Analytics, Inc.'s Notice of Motion and Motion for Leave to File Cross-Complaint;

2. Defendant Gradient Analytics, Inc.'s Memorandum of Points and Authorities in Support of Motion for Leave to File Cross Complaint;

3. Declaration of Brian P. Maschler, Esq. in Support of Defendant Gradient Analytics, Inc.'s Motion for Leave to File Cross Complaint; [Note: Exhibit A to this document includes Gradient's Cross Complaint];

4. [Proposed] Order Granting Defendant Gradient Analytics, Inc. Leave to File Cross-Complaint

The subject matter of's press release was an update in connection with its ongoing litigation between Overstock and Gradient. Since updated the public about the status of its litigation with Gradient in its press release, under rule 10b and 10b-5, the company cannot cherry pick only so-called favorable information and at the same time exclude new materially negative information.

Overstock cannot present a tenable legal argument to overcome the fact that, more likely than not, some members of the public would have included the omitted information of Gradient's request to file its countersuit in their decisions in connection with trading the securities of the company. The disclosure of Gradient's request to file its countersuit would have clearly altered the mix of information to the readers of its press release.

In short, the standard is not if, more likely then not, all members of the public would have included the omitted information---the standard is whether it is "reasonable to assume" that some members of the public would have included the omitted information in their decisions in connection with the trading of's securities.

Written by:

Sam E. Antar (former Crazy Eddie CFO and a convicted felon)


Popular Posts

Did a Clever SEC Bait Goldman Sachs into Compounding Its Legal Problems With the "Kiss of Death" Message?

Updated: At 3:48 AM ET 04/20/2010 on bottom

The Kiss of Death

In filing its lawsuit against Goldman Sachs (NYSE: GS) on a Friday, the Securities and Exchange Commission sent what I call the "kiss of death" message to the embattled company. In other words, the SEC wanted to stick it to Goldman Sachs and Fabrice Tourre, the Executive Director of Goldman Sachs International, who is also a defendant in the complaint. While the SEC as a practice does inform target companies and individuals of an impending enforcement action, it does not always tell them exactly when such an action will be filed.

Apparently, the SEC filed its lawsuit without giving Goldman Sachs the heads up that it was planning to file it that day. Business Insider observed that Goldman Sachs was clearly unprepared to respond to the complaint as news of the lawsuit dominated the headlines all day. Goldman issued a short denial around noon and issued an extensive denial late in the afternoon, after most people had … CEO Patrick Byrne Sleeps With a Gun

In numerous blog posts in the past, and in widespread media coverage, evidence has accumulated for years that CEO (NASDAQ: OSTK) Patrick Byrne has shown signs of being mentally unbalanced and paranoid.

Byrne has blamed his company's financial woes on an unnamed "Sith Lord." He hired paid goons to stalk his real and imagined adversaries and to write lengthy conspiracy theories on the Internet. Byrne has close ties with Bo Gritz. The Anti-Defamation League lists Bo Gritz as a far-right extremist with “extensive connections to both white supremacists and anti-government groups and leaders.”

Patrick Byrne's infamous temper tantrums when he doesn’t get want he wants are well documented too. He made obscene and misogynistic comments to a female reporter. He suggested that she gave “blowjobs” to Goldman Sachs traders. He suggested that a male reporter “Sucks It Likes He’s Paying the Rent.” An independent research analyst was told that “You deserve to be whippe…

Nature's Sunshine Products, Willbros Group, Cal Dive International, and BSQUARE Violate S.E.C. Rules on Calculating EBITDA

Nature’s Sunshine Products (NASDAQ: NATR), Willbros Group (NYSE: WG), Cal Dive International (NYSE: DVR), and BSQUARE (NASDAQ: BSQR) have recently issued earnings reports which include a calculation of EBITDA (earnings before interest, taxes, depreciation, and amortization) that apparently does not comply with Securities and Exchange Commission interpretations for Regulation G governing such non-GAAP financial measures. In each case, their erroneous EBITDA calculations have enabled them to significantly distort their financial performance by erroneously reporting a positive EBITDA, when they should have reported a negative EBITDA in the latest quarter.

How EBITDA is supposed to be calculated under Regulation G

According to the S.E.C. Compliance & Disclosure Interpretations, EBITDA is defined under Regulation G as net income (not operating income) before net interest, taxes, depreciation, and amortization. See below:

Question 103.01Question: Exchange Act Release No. 47226 describes E…

InterOil, John Thomas Financial, and Clarion Finanz: Anatomy of a Stock Market Manipulation Scheme

In this blog post, I will provide evidence of what I believe is a stock market manipulation scheme involving InterOil (NYSE: IOC), John Thomas Financial, and Clarion Finanz AG. I believe that InterOil with the assistance of Clarion Finanz concealed John Thomas Financial’s involvement in helping it raise $95 million through a private placement of convertible debt securities.

Clarion Finanz acted as a buffer between InterOil and John Thomas Financial to help InterOil hide John Thomas Financial's role in raising funds. Afterwards, InterOil filed false and misleading reports with the Securities and Exchange Commission in an effort to conceal John Thomas Financial’s role in helping the company raise $95 million in convertible debt.

Carl Caserta, who in 1991 was barred by the Securities and Exchange Commission from “association with any broker, dealer, or investment advisor” played a role in helping InterOil use John Thomas Financial to obtain funds from investors. InterOil, John Thoma…

Class Action Complaint against Amedisys uses Sarbanes-Oxley Act Corporate Governance Provisions to Battle Alleged Corporate Malfeasance

Updated at bottom of article

Last week, Pomerantz Haudek Grossman & Gross LLP filed a class action lawsuit against Amedisys (NASDAQ: AMED) charging the company, its CEO William F. Borne and its CFO Dale E. Redman with securities fraud.  In the next few days, Bernstein Liebhard LLP and Finkelstein Thompson LLP filed similar class action lawsuits against the company. The lawsuits allege that Amedisys abused Medicare's reimbursement system for at-home therapy care based on a compelling analysis of company revenues in an April 27 Wall Street Journal article.

In addition, the lawsuits innovatively utilize a provision under Section 406 of the Sarbanes-Oxley Act 2002 which provides a back-door way for investors to force ethical corporate governance and sue public companies for malfeasance. That provision requires Senior Financial Officers, such as the CEO and CFO of public companies, to abide by a strict code of ethics which broadly defines corporate malfeasance and effectively makes…